Remarkably, prolonged PFS was observed in the low STX17-DT expression group, indicating that STX17-DT might play an important role in axitinib resistance in ccRCC (Fig. 2I and Supplementary Tables 1, 2). Here, STX17 is linked to nonpapillary renal cell carcinoma.